Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32:320-1) and Drs. Marr and Boeckh (Clin Infect Dis 2001; 32:321)

Comment

J H Rex et al. Clin Infect Dis. 2001.

. 2001 Feb 1;32(3):518-9.

doi: 10.1086/318517.

No abstract available

Comment on

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America.
Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, Pizzo P, Rolston KV, Shenep JL, Young LS. Hughes WT, et al. Clin Infect Dis. 1997 Sep;25(3):551-73. doi: 10.1086/513764. Clin Infect Dis. 1997. PMID: 9314442 Review.
Empirical antifungal therapy for persistent fever in patients with neutropenia.
Chandrasekar PH. Chandrasekar PH. Clin Infect Dis. 2001 Jan 15;32(2):320-1. doi: 10.1086/318455. Clin Infect Dis. 2001. PMID: 11170928 No abstract available.
Practice guidelines for fungal infections: a risk-guided approach.
Marr K, Boeckh M. Marr K, et al. Clin Infect Dis. 2001 Jan 15;32(2):321. doi: 10.1086/318458. Clin Infect Dis. 2001. PMID: 11170929 No abstract available.